Professor Marwan Ghosn obtained his medical degree and postgraduate expertise in Hematology and Oncology from the Faculty of Medicine, Saint Joseph University of Beirut, Lebanon as well as from the University of Paris XI – Kremlin-Bicêtre, Paris – Saclay, and Institute Gustave Roussy Cancer Center in Villejuif, France.

He also holds a master’s degree in Hospital and Health Management from The Higher School of Business, ESA, in Beirut and a Master’s degree in the Quality Management of Units for Care Production (MUPS) from the University of Paris VII, Denis Diderot, France.

For nearly thirty years, he served as Director of the Hematology Oncology Post Graduate Program and Chairman of the Hematology Oncology Department at Saint Joseph University of Beirut, Faculty of Medicine in Beirut.

Professor Marwan Ghosn also served for more than 12 years as Chairman of the Hematology-Oncology Department at Hôtel-Dieu de France University Hospital in Beirut.

He also served as the Director of the Cancer Center and the Head of Hematology Oncology Division at Clemenceau Medical Center affiliated with Johns Hopkins International in Beirut- Lebanon.

He is currently a Consultant in Clinical Hematology and Medical Oncology at Hôtel-Dieu de France University Hospital in Beirut, Clemenceau Medical Center, affiliated with Johns Hopkins International, in Beirut and in Dubai, and Burjeel Cancer Institute and Burjeel Medical City in Abu Dhabi-UAE.

He served as President of the Lebanese Society of Medical Oncology (LSMO) and was member of the Board of the Lebanese Cancer Society (LCS) for many years. He is an active member of several national and international scientific organizations and societies including the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), the European Society of Medical Oncology (ESMO), the American Society of Hematology (ASH), the European Hematology Association (EHA), the International Society of Geriatric Oncology (SIOG), Africa Middle East Cancer Intergroup (AMCI), and the Arab Medical Association Against Cancer (AMAAC).

He is the author and co-author of more than 300 peer-reviewed articles. He also published and gave an extensive number of communications, posters and abstracts at regional and international meetings, as well as several chapters in books of Medical Oncology and Health Care Management.

He is the Editor-in-Chief of the “Pan Arab Journal of Oncology” (PAJO) edited by the Arab Medical Association Against Cancer (AMAAC) and has previously served as Editor-in-Chief of the “Cancer Letter” edited by the Lebanese Cancer Society.

Professor Ghosn has special interests in multiple areas including research and clinical trials across solid tumors. He has expertise in breast cancer, urologic cancers, gastrointestinal tumors, geriatric oncology domain, personalized and oncogenomic-oriented therapy, as well as in patients’ safety and Quality in healthcare.